Cosmetic and aesthetic clinic marketing sits in a difficult commercial position in 2026. Consumer demand can be strong, visual channels matter and treatments can be highly searchable, but the marketing is being judged against medicine rules, cosmetic intervention rules, platform restrictions, body image standards and increasingly proactive advertising monitoring.
WLW FUTURE reviewed the current public position across the ASA, CAP, MHRA, Google, Meta and TikTok alongside the latest 2026 enforcement evidence. The commercial question is not simply whether a clinic can advertise. It is which service can be promoted, which claims can be supported, which audience can be reached and which channel is appropriate for that particular treatment.
Research boundary
This is a B2B marketing and digital intelligence report. Regulatory sources are linked throughout. Clinics should obtain appropriate legal, regulatory and clinical advice for specific advertising, prescribing and treatment decisions.
This is a B2B marketing and digital intelligence report. Regulatory sources are linked throughout. Clinics should obtain appropriate legal, regulatory and clinical advice for specific advertising, prescribing and treatment decisions.
928unique paid Meta ads captured in the ASA liquid BBL monitoring project
11.5%of assessed liquid BBL ads complied by December 2025
353ads from 15 advertisers identified with irresponsible claims in the ASA sweep
18+cosmetic intervention advertising must not be directed at people below 18
The headline findings for aesthetic clinic marketing in 2026
The current evidence points to a market where the clinic can still build demand, but shortcuts around urgency, medicine naming, risk, body image and audience selection create disproportionate exposure.
Age targeting is a core rule
CAP Code rule 12.25 prohibits cosmetic intervention marketing from being directed at people below 18 through the media or context selected. The ASA also says non broadcast ads should not appear in media where under 18s make up 25% or more of the audience.
Botox remains a prescription medicine issue
Botox and other botulinum toxin products are prescription only medicines and cannot be advertised to the public. Current CAP guidance says clinics should promote the consultation rather than the medicine.
Urgency can become irresponsible
The ASA liquid BBL enforcement project identified time limited offers as one of the recurring problems. Scarcity and urgency are particularly sensitive where they can pressure somebody into a cosmetic intervention.
Body confidence language needs judgement
The same ASA project identified ads that exploited body image insecurities, including claims connecting procedures with confidence or an ideal body shape. Marketing teams need to distinguish reassurance from pressure.
The landing page is part of the advert
Platform review and medicine rules can extend beyond the creative. Treatment naming, pricing, claims and the path from a homepage into consultation and treatment information all matter.
Platform eligibility changes by treatment
TikTok currently permits some aesthetic treatments in the UK subject to permission and adult targeting while Botox is expressly listed as not allowed. Google applies separate health and personalised advertising restrictions. Meta reviews the creative, targeting and destination.
The 2026 enforcement picture is much more active
The strongest current aesthetics evidence comes from the ASA’s March 2026 enforcement report on non surgical liquid Brazilian Butt Lifts. The ASA used its AI based Active Ad Monitoring system to capture paid Meta advertising between April and December 2025.
The liquid BBL project shows the type of claims regulators are actively finding
The report describes a high level of non compliance and gives marketers a useful view of the patterns attracting attention.
928unique paid Meta ads captured during the monitoring periodASA Enforcement Report
11.5%of assessed ads complied with the social responsibility rules by December 2025ASA Enforcement Report
3 themestime limited offers, downplaying medical risk and exploiting body image insecurities were recurring problemsASA summary
MHRA activity also remained relevant during 2026. Its April and June advertising investigation decisions include aesthetic services which amended advertising after action concerning public promotion of prescription only medicines. MHRA June 2026
What cosmetic and aesthetic clinics can advertise
The starting point changes according to the treatment. A clinic brand, a consultation, dermal fillers, a laser treatment and a prescription only medicine should not be treated as one advertising category.
| Treatment or offer | UK advertising starting point | Primary issue | Marketing risk |
|---|---|---|---|
| Clinic brand and consultation | Can generally be promoted subject to claims, professional status, consumer law and treatment specific restrictions | Do not let a general clinic advert become an indirect route to unlawful medicine promotion | Lower starting risk |
| Botox and other botulinum toxin POMs | Cannot be advertised to the public | Direct and indirect references, promotions, social posts, efficacy claims and easy public access to promotional medicine information | High risk |
| Dermal fillers | Service advertising can be possible | Under 18 targeting, exaggerated outcomes, risk, social responsibility, urgency and platform eligibility | Review required |
| Skin boosters and injectable hydration treatments | Service advertising can be possible where the treatment is not a POM and the claims are compliant | Product status, claims, targeting, imagery, qualification statements and platform restrictions | Review required |
| Laser, light and skin treatments | Can generally be advertised with appropriate evidence and responsible presentation | Outcome claims, before and after imagery, risk, under 18 targeting and device or medical claims where relevant | Review required |
| Surgical cosmetic procedures | Advertising is subject to cosmetic intervention rules and broader responsibility requirements | Under 18 targeting, pressure, body image, risk and platform restrictions | High scrutiny |
Interactive clinic marketing risk checker
Check the pressure points before the campaign goes live
Choose the closest treatment, channel and creative feature. The result is a marketing screening tool based on the public sources reviewed for this report. It does not replace legal or regulatory advice.
1. What are you promoting?
2. Which channel is central?
3. What does the creative use?
4. Is adult targeting fully controlled?
Lower risk starting point
Keep the treatment, claims and destination aligned
A clinic or consultation campaign with controlled adult targeting and no obvious high risk claim has a more manageable starting position. Review the treatment detail, substantiation, platform rules and landing page before launch.
Under 18 targeting and body image are central marketing issues
CAP Code rule 12.25 states that cosmetic intervention marketing must not be directed at people below 18 through the selection of media or context. CAP’s current guidance says this covers surgical and non surgical interventions where the main purpose is to change appearance. CAP Code Section 12
For non broadcast media, CAP guidance explains that ads should not appear in media where under 18s make up 25% or more of the audience. On social media the advertiser needs to take reasonable steps to avoid reaching under 18s. CAP Bitesize
The body image point is commercially harder. A clinic naturally wants to communicate appearance outcomes and confidence. The ASA liquid BBL project shows the point at which this can become irresponsible: claims which exploit insecurities or connect an intervention with an idealised body or emotional pressure can attract action.
Botox marketing needs its own customer journey
Botox and other botulinum toxin products are prescription only medicines. CAP guidance states that they cannot be advertised to members of the public. The same guidance warns against indirect references which clearly point to Botox and against price promotions or giveaways involving the medicine. CAP Botox guidance
A clinic website can contain limited factual information in a carefully structured journey. CAP says the consultation should be the focus and balanced factual information about Botox may appear deeper within the website as a possible treatment outcome. Price information can also be possible in a genuine treatment price list where the medicine is not promoted through claims or discounts and the casually browsing visitor does not encounter it with ease. CAP POM website guidance
1. Clinic needThe visitor arrives around a concern, clinic brand or consultation need rather than a promoted prescription medicine.
2. ConsultationThe website explains assessment, practitioner role, suitability and what the consultation covers.
3. OptionsBalanced information can explain possible treatment routes without pushing a prescription medicine.
4. Factual detailWhere appropriate, deeper website pages can provide balanced medicine information consistent with regulatory guidance.
5. Clinical decisionTreatment follows professional assessment and suitability rather than a promotional promise.
Google, Meta and TikTok create a second compliance layer
UK advertising rules and platform eligibility are separate checks. A treatment can be lawful to market in principle while the chosen platform applies tighter rules around health, medicine, targeting or cosmetic procedures.
| Channel | Current practical position | What clinics should check |
|---|---|---|
| Google treats invasive medical procedures including cosmetic surgery and injections as sensitive health content in personalised advertising. Prescription drug terms are separately restricted. | Audience strategy, treatment wording, medicine terms, landing pages and whether health related personalised targeting is being attempted | |
| Meta | Meta says ad review can assess creative, targeting and the destination. Its ad systems restrict sensitive health audience options and UK prescription drug promotion is not within the countries currently listed for authorised POM advertising. | Creative, destination, health audience assumptions, body image presentation, POM references and post launch review |
| TikTok | TikTok’s June 2026 UK policy allows some aesthetic treatments subject to permission and 18+ targeting. It lists examples including fillers, skin boosters, PRP and chemical peels while Botox is not allowed. | Eligibility with TikTok, adult targeting, treatment category, before and after imagery, body image and exaggerated claims |
| Organic social and influencers | CAP rules still apply where content is a marketing communication. POM restrictions, disclosure, claims, imagery and audience remain relevant. | Commercial relationship, medicine references, claims, age, editing or filters and whether the post creates a promotional treatment promise |
The strongest clinic marketing reduces uncertainty before asking for a booking
Compliance and conversion are closely connected in aesthetics. The same information which reduces regulatory ambiguity can also make a clinic easier to trust: who provides the treatment, what happens in consultation, what the treatment is designed to address, realistic outcomes, risks, pricing context and what happens next.
Explain the consultation
Make the clinical assessment and suitability process useful content rather than a generic booking step.
Make practitioner credibility clear
Qualifications, registration, relevant experience and scope should be easy to understand without inflated expert claims.
Give price context
Help people understand consultations, treatment ranges and what changes final cost where this can be done responsibly.
Use reviews with context
Patient evidence is more useful when it relates to a service, concern or part of the clinic experience rather than sitting as a generic feed.
Build search depth
Organic content can answer treatment, suitability, recovery, consultation and safety questions in more depth than paid creative.
Measure the full journey
Track search visibility, enquiry quality, consultation bookings, treatment conversion and the points where users abandon the journey.
Benchmark your current aesthetic clinic marketing
Use this scorecard as a quick internal benchmark. A high score does not certify compliance. It shows whether the main marketing controls are connected before campaigns are scaled.
Current benchmark score
0/10
Start with the fundamentals
The current setup appears to rely on disconnected checks. Build a documented clinic marketing review around treatment status, claims, audience, channel, website and evidence.
Where compliant growth remains for cosmetic and aesthetic clinics
The regulatory pressure does not remove the commercial opportunity. It changes where the strongest marketing advantage sits. Clinics which depend on aggressive offers, medicine led promotion or transformation language become easier to disrupt. Clinics which build trust, useful search visibility, better consultation journeys and stronger evidence have more defensible routes to growth.
Own treatment questions
Build the strongest useful content around suitability, process, recovery, practitioner choice, risk and realistic expectations.
Win local search
Connect clinic location pages, treatment pages, reviews, practitioner expertise and Google Business Profile activity into one local visibility system.
Improve consultation conversion
Measure the route from search or paid media to consultation request and remove uncertainty before the user is asked for personal details.
Build AI citation readiness
Use clear treatment definitions, expert reviewed information, evidence and structured pages so the clinic becomes easier for AI systems to understand and cite.
Separate acquisition by treatment
A clinic brand campaign, dermal filler campaign and prescription medicine journey should have different channel and content strategies.
Turn compliance into trust
Responsible language, clear credentials, transparent consultation and realistic treatment information can strengthen the brand as well as reduce risk.
WLW FUTURE aesthetic clinic digital opportunity review
See where your clinic is exposed and where it can grow
WLW FUTURE can review your website, search visibility, AI visibility, treatment journeys, advertising, competitor position, claims, customer data and conversion routes together. The output is a prioritised view of the compliance risks and the commercial opportunities.
Request an aesthetic clinic digital opportunity reviewFrequently asked questions
Can aesthetic clinics advertise Botox in the UK?
Botox and other botulinum toxin products are prescription only medicines and cannot be advertised to the public. CAP guidance says clinics should promote the consultation rather than the medicine. Limited balanced factual information may appear deeper within a carefully structured website journey.
Can a clinic advertise dermal fillers?
Dermal filler service advertising can be possible, but cosmetic intervention rules still apply. The marketing needs adult targeting, responsible claims, appropriate evidence and platform eligibility. TikTok currently lists dermal fillers among aesthetic treatments which may be allowed in the UK subject to permission and 18+ targeting.
Can cosmetic treatment adverts target people under 18?
No. CAP Code rule 12.25 says cosmetic intervention marketing must not be directed at people below 18 through the media or context selected. CAP guidance also describes the audience composition rule for non broadcast media.
Are before and after images banned?
There is no single blanket rule which makes every before and after image unlawful across every cosmetic treatment. They are treated as efficacy claims and can become misleading if the comparison exaggerates results. For prescription medicines such as Botox, CAP says before and after photographs are promotional efficacy claims and are not permitted as part of public POM promotion. Platform rules can be stricter for some aesthetic categories.
Can an aesthetic clinic use limited time offers?
Promotional urgency needs particular care in cosmetic interventions. The ASA liquid BBL enforcement report identified time limited claims as a recurring social responsibility problem. POM price promotions such as discounts on Botox are also not acceptable.
Can TikTok be used for aesthetic clinic advertising in the UK?
TikTok’s June 2026 policy says some aesthetic treatments may be allowed in the UK if the advertiser works with TikTok to determine eligibility and obtain permission and restricts advertising to people aged 18 or over. Botox is listed as not allowed and elective surgery is not allowed.
Does Google treat aesthetic treatments as sensitive health advertising?
Google’s current personalised advertising policy includes invasive medical procedures such as cosmetic surgery, surgical procedures and injections within sensitive health content. Clinics should review the targeting strategy as well as the creative and landing page.
Does the clinic website need a separate compliance review?
Yes. The website can contain treatment naming, price information, claims, practitioner credentials and medicine references which create separate issues from the original advert. Platform review can also consider the destination page.
What should an aesthetic clinic prioritise for digital growth?
The strongest commercial priorities are usually treatment specific search visibility, local search, credible practitioner information, useful consultation journeys, evidence based claims, relevant reviews, measurement and channel strategies which reflect the regulatory position of each treatment.
Sources and methodology
- CAP Code Section 12. Used for the under 18 cosmetic intervention rule and medicines framework.
- ASA and CAP guidance on surgical and non surgical cosmetic procedures. Used for claims, responsibility, targeting, qualifications and before and after presentation.
- CAP Botox and non surgical cosmetic interventions guidance. Used for Botox, consultation led website journeys, price lists and under 18 advertising.
- ASA Enforcement Report: non surgical liquid BBLs. Published 12 March 2026. Used for the paid advertising monitoring figures and social responsibility findings.
- MHRA medicinal treatment services decisions, June 2026. Used as current evidence of POM advertising action involving an aesthetics service.
- MHRA guidance on advertising medicines. Used for the prohibition on public POM advertising.
- Google health in personalised advertising policy. Used for sensitive health targeting and invasive medical procedure examples.
- Meta ad review guidance. Used for the scope of automated review across creative, targeting and destination.
- Meta drugs and pharmaceuticals advertising policy. Used for current prescription medicine country eligibility.
- TikTok Healthcare and Pharmaceuticals policy. Last updated June 2026. Used for UK cosmetic clinic and aesthetic treatment eligibility.
Research note: This first benchmark draft combines current public regulatory evidence with a WLW digital marketing scorecard. It does not claim to be a scored ranking of named UK clinics. A separate competitor audit can be added once the clinic sample, search set and scoring methodology are agreed.
Image note: Pexels links are suggestions only. Download, optimise and host chosen images within the WLW media library before publishing where practical.
